PHARMASGP
PharmaSGP is a pharmaceutical company with a broad portfolio of leading non-chemical, over-the-counter (OTC) drugs and other healthcare products. The drugs are based on natural pharmaceutical active ingredients with documented efficacy and have virtually no known side effects. PharmaSGP is the market leader in Germany for systemic, chemical-free OTC pain relievers with the brands RUBAXX for rheumatic pain and RESTAXIL for neuralgic pain (nerve pain). The company portfolio also includes products in the categories of sexual weakness, vertigo and skin aging.
PHARMASGP
Industry:
Health Care Pharmaceutical
Address:
Gräfelfing, Bayern, Germany
Country:
Germany
Website Url:
http://www.sgp-pharma.com
Total Employee:
101+
Status:
Active
Contact:
49 (0) 611 20 58 55 28
Email Addresses:
[email protected]
Technology used in webpage:
Euro ReCAPTCHA COVID-19 MailChimp 3 To 9 CcTLD Redirects
Official Site Inspections
http://www.sgp-pharma.com
- Host name: 185.175.196.17
- IP address: 185.175.196.17
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "PharmaSGP"
PharmaSGP - Crunchbase Company Profile & Funding
PharmaSGP is a pharmaceutical company with a broad portfolio of leading non-chemical, over-the-counter (OTC) drugs and other healthcare products.See details»
Investor Relations - PharmaSGP Holding SE
Jun 10, 2020 The Management Board of PharmaSGP Holding SE has decided on January 3, 2023, with the approval of the Supervisory Board, utilizing the authorization of the General …See details»
PharmaSGP – Wikipedia
PharmaSGP Holding SE (auch PharmaSGP) mit Sitz in Gräfelfing bei München ist ein deutsches, börsennotiertes Pharmaunternehmen, das sich auf die Entwicklung und den Vertrieb von nicht verschreibungspflichtigen Arzneimitteln (over-the-counter „OTC“) und anderen Gesundheitsprodukten spezialisiert hat. Der Vertrieb der Produkte erfolgt hauptsächlich in Apotheken. Neben dem Ausbau des Produktportfolios und der regionalen Expansion in Europa …See details»
PharmaSGP Holding SE - Org Chart, Teams, Culture & Jobs | The Org
View PharmaSGP Holding SE's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Investor Relations | PharmaSGP Holding SE
Investor Relations-Portal der PharmaSGP Holding SE, einem führenden Consumer-Health-Unternehmen mit Fokus auf natürliche und rezeptfreie OTC-Arzneimittel.See details»
PharmaSGP Holding - Products, Competitors, Financials, …
PharmaSGP Holding SE has purchased 477,701 own shares through its public share repurchase offer. Oct 1, 2024. PharmaSGP Holding SE has purchased 477,701 own shares through its …See details»
PharmaSGP Holding - PitchBook
PharmaSGP Holding General Information Description. PharmaSGP Holding SE is a pharmaceutical company. The company develops chemical-free, over-the-counter (OTC) …See details»
PharmaSGP : strengthens Management Board for a consistent ...
Sep 1, 2020 cometis AG Claudius Krause Phone: 0611-20585528 Email: [email protected]. ABOUT PHARMASGP HOLDING SE. PharmaSGP is a pure-play consumer health company …See details»
Contact - PharmaSGP Holding SE
For general enquiries, please contact our customer service.You may simply use the contact form below or call us: +49(0)89 / 85 89 639 – 150. We can be reached from Monday to Thursday …See details»
PharmaSGP Holding SE valued at €378 million at IPO
Jun 18, 2020 Email: [email protected]. ABOUT PHARMASGP HOLDING SE. PharmaSGP is a pure-play consumer health company with a broad portfolio of leading chemical-free non …See details»
PharmaSGP Holding SE | PSG - Financial Reports
May 10, 2022 Access PharmaSGP Holding SE's (PSG) 2023 annual report and investor relations data on FinancialReports.eu. Explore comprehensive financial insights, performance …See details»
PharmaSGP Holding SE, PSGX:GER summary - FT.com - Financial …
4 days ago EQS-DD: PharmaSGP Holding SE: FUTRUE GmbH, buy Nov 25 2024; EQS-News: PharmaSGP with strong revenues growth in 9M 2024 – revenues forecast for FY 2024 raised …See details»
PharmaSGP confirms record revenue and record profitability
Mar 15, 2023 CONTACT. cometis AG Claudius Krause Telephone: +49-611-20585528 Email: [email protected]@sgp-pharma.com . ABOUT PHARMASGP HOLDING SE. PharmaSGP …See details»
PharmaSGP successfully secures financing of up to € 160 million
Gräfelfing, 21 July 2022 – Following strong organic growth and the successful acquisition and integration of the four OTC brands Baldriparan®, Formigran®, Spalt® and Kamol® formerly …See details»
PharmaSGP reporting 34% revenue growth and increased …
Nov 16, 2021 DGAP-News: PharmaSGP Holding SE / Key word(s): Preliminary Results/9 Month figures16.11.2021 / 07:30 The issuer is solely responsible for the content of this …See details»
PharmaSGP: Das plant Unternehmer Clemens Fischer als nächstes
Jul 6, 2020 PharmaSGP Was der rastlose Pharmaunternehmer Clemens Fischer als Nächstes plant Im Juni brachte der Unternehmer PharmaSGP an die Börse. Nun sucht er nach neuen …See details»
PSG: PharmaSGP Holding SE Stock Price Quote - Xetra - Bloomberg
Nov 14, 2024 Stock analysis for PharmaSGP Holding SE (PSG:Xetra) including stock price, stock chart, company news, key statistics, fundamentals and company profile.See details»
PharmaSGP Holding als Arbeitgeber: Gehalt, Karriere, Benefits
PharmaSGP Holding wird als Arbeitgeber von Mitarbeitenden mit durchschnittlich 4,4 von 5 Punkten bewertet. In der Branche Medizin/Pharma schneidet PharmaSGP Holding besser ab …See details»
Sun Pharma - Wikipedia
Sun Pharmaceutical Industries Limited (d/b/a Sun Pharma) is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells …See details»
Pharma 4.0™: Case Studies and Lessons Learned
1 day ago As the pharmaceutical industry navigates the complexities of digital transformation, the concept of Pharma 4.0™ emerges as a pivotal framework for integrating advanced …See details»